Integer (NYSE:ITGR) will be issuing its quarterly earnings data before the market opens on Thursday, February 21st. Analysts expect the company to announce earnings of $0.92 per share for the quarter.
ITGR stock opened at $80.90 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.32 and a current ratio of 2.41. The stock has a market cap of $2.63 billion, a price-to-earnings ratio of 28.79 and a beta of 0.96. Integer has a 1-year low of $43.25 and a 1-year high of $90.03.
In related news, Director Pamela G. Bailey sold 5,767 shares of the company’s stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $83.16, for a total transaction of $479,583.72. Following the sale, the director now owns 53,562 shares in the company, valued at $4,454,215.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Joseph F. Flanagan sold 13,633 shares of the company’s stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $86.42, for a total value of $1,178,163.86. Following the sale, the executive vice president now owns 12,622 shares in the company, valued at approximately $1,090,793.24. The disclosure for this sale can be found here. Insiders own 3.60% of the company’s stock.
ITGR has been the topic of several recent analyst reports. TheStreet lowered Integer from a “b” rating to a “c+” rating in a report on Friday, November 2nd. Zacks Investment Research upgraded Integer from a “hold” rating to a “buy” rating and set a $91.00 price target on the stock in a report on Friday, January 18th. KeyCorp boosted their price target on Integer from $81.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, November 2nd. Finally, Royal Bank of Canada boosted their price target on Integer to $84.00 in a report on Friday, November 2nd. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $85.80.
TRADEMARK VIOLATION WARNING: This report was first published by Modern Readers and is owned by of Modern Readers. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.modernreaders.com/news/2019/02/14/integer-itgr-scheduled-to-post-quarterly-earnings-on-thursday.html.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.
Read More: Is the QQQ ETF safe?
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.